Atossa Therapeutics Inc. News

Latest updates and market news for ATOS

2 news

Jan 1 - Jan 7, 2026

Page 1

MT Newswires

11 hours ago

Atossa Therapeutics Says FDA Clears Z-endoxifen Study in Metastatic Breast Cancer

Atossa Therapeutics Receives FDA "Study May Proceed" Letter for (Z)-Endoxifen Investigational New Drug Application for Metastatic Breast Cancer

PR Newswire

12 hours ago

Atossa Therapeutics Receives FDA "Study May Proceed" Letter for (Z)-Endoxifen Investigational New Drug Application for Metastatic Breast Cancer

Share this news page

Share on Social Networks: